| Dr Troy Andrew Munson, MD | |
|
1111 6th Ave, Suite: B1, Des Moines, IA 50314-2613 | |
| (515) 358-0100 | |
| (515) 358-0109 |
| Full Name | Dr Troy Andrew Munson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 18 Years |
| Location | 1111 6th Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992951370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 125052152 (Illinois) | Secondary |
| 207T00000X | Neurological Surgery | 40815 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Mercyone Newton Medical Center | Newton, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinics Inc | 7911810882 | 373 |
News Archive
It is known that some people have the "delusional bug syndrome" and are convinced that bugs, worms, germs, or other creepy crawlers are infesting their skin and often see skin doctor after skin doctor to find out what is causing the infestation. Often, patients bring in samples of the insect and request a skin biopsy.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from "death cap" mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.
QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).
President Obama officially declared June as Lesbian, Gay, Bisexual and Transgender (LGBT) Pride Month. However, despite advances in civil rights, sexual minority youth are still at greater risk for suicide than their heterosexual peers, according to the Suicide Prevention Resource Center.
› Verified 4 days ago
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
It is known that some people have the "delusional bug syndrome" and are convinced that bugs, worms, germs, or other creepy crawlers are infesting their skin and often see skin doctor after skin doctor to find out what is causing the infestation. Often, patients bring in samples of the insect and request a skin biopsy.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from "death cap" mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.
QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).
President Obama officially declared June as Lesbian, Gay, Bisexual and Transgender (LGBT) Pride Month. However, despite advances in civil rights, sexual minority youth are still at greater risk for suicide than their heterosexual peers, according to the Suicide Prevention Resource Center.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Troy Andrew Munson, MD Po Box 4925, Des Moines, IA 50305-4925 Ph: (515) 358-0100 | Dr Troy Andrew Munson, MD 1111 6th Ave, Suite: B1, Des Moines, IA 50314-2613 Ph: (515) 358-0100 |
News Archive
It is known that some people have the "delusional bug syndrome" and are convinced that bugs, worms, germs, or other creepy crawlers are infesting their skin and often see skin doctor after skin doctor to find out what is causing the infestation. Often, patients bring in samples of the insect and request a skin biopsy.
Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System. The device is now approved for use in improving coronary artery luminal diameter in patients with symptomatic ischemic heart disease.
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from "death cap" mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.
QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).
President Obama officially declared June as Lesbian, Gay, Bisexual and Transgender (LGBT) Pride Month. However, despite advances in civil rights, sexual minority youth are still at greater risk for suicide than their heterosexual peers, according to the Suicide Prevention Resource Center.
› Verified 4 days ago
Dr. David J Boarini, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 | |
Zoya A. Voronovich, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave Ste B1, Des Moines, IA 50314 Phone: 515-358-0100 Fax: 515-358-0109 | |
Dr. Thomas A Carlstrom, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1215 Pleasant St, Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 Fax: 515-241-8161 | |
Dr. Timothy C Ryken, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 Fax: 515-241-8161 | |
Nicholas M Wetjen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-241-5760 | |
Dr. Royce W Woodroffe, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 | |
Dr. Joseph Edward Sherrill Ii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St, Ste 608, Des Moines, IA 50309 Phone: 515-875-9560 Fax: 515-875-9561 |